106 results on '"Odenthal M"'
Search Results
2. Expression analysis of mRNAs of extracellular matrix components in aggressive entities of salivary gland carcinomas
3. Influence on hepatocellular carcinoma energy metabolism by pharmacological inhibition of the epigenetic modifier LSD1
4. Overexpression of tumor suppressor miR-198 in hepatoma cells leads to its spontaneous and active export via vesicles
5. Sequential (epi)genetic changes during liver cancer development and progression
6. Expression von Tumor-treibenden Signalwegen bei adenoid-zystischen Karzinomen der Glandula parotis
7. Expression of tumor-driving pathways and genes in adenoid cystic carcinoma of the parotid gland
8. Oxidative Stresssignaturen korrelieren bei einer Subgruppe oropharyngealer Plattenzellkarzinome mit einem mesenchymalen Phänotyp und ungünstiger Prognose
9. Oxidative stress signatures are related with a mesenchymal-like phenotype and an unfavorable prognosis in a subgroup of oropharyngeal squamous cell carcinoma
10. Epigenitic Modifications by the Histone Demethylase LSD1 in Hepatic Stellate Cells Contribute to Liver Fibrosis
11. Landscape of (epi-)genetic alterations during malignant transformation in liver cancer
12. MiR-198 overexpression leads to its vesicular release from hepatocellular carcinoma cells
13. Metabolic Changes upon Inhibition of the Lysine-Specific-Demethylase-1 (LSD1) in Hepatocellular Carcinoma
14. ESR1 Promotor-Methylierung in primären Mammakarzinomen und zugehörigen Metastasen
15. The epigenetic writer LSD1 controls hepatic cell cycle progression by alteration of global expression profiles and protein signatures
16. The lysine-specific histone demethylase LSD1 controls cell cycle progression in liver fibrosis and cancer by alteration of protein expression profiles
17. The lysine specific histone demethylase LSD1 in activated Hepatic Stellate Cells contributes to liver fibrosis
18. The Epigenetic Modifications by the Histone Demethylase LSD1 in Hepatic Stellate Cells Contribute to Liver Fibrosis
19. Differentiated Liver Damage by Acetaminophen in a Human Ex-Vivo Liver Model
20. Tumor suppressor microRNA-198 is actively transported out of liver cancer cells
21. ESR1-Promotor-Methylierung und ER-Rezeptorexpression beim metastasierenden Mammakarzinom
22. Einfluss der kombinierten Gabe von Telmisartan und Propranolol im Mdr 2 -/- knockout Mausmodell auf Tight Junctions der Leber
23. microRNA-223 als Marker für intraduktale papilläre muzinöse Neoplasien (IPMN) des Pankreas: Ergebnisse einer prospektiven multizentrischen Studie zur endosonographisch gesteuerten Punktion zystischer Pankreasraumforderungen
24. Zusammenhang der zirkulierenden miRNA-122 Spiegel mit der portalen Hypertension bei HIV/HCV-positiven Patienten
25. Comprehensive analysis of informative target disease relevant nuclear genes and the whole mitochondrial genome in hepatocellular carcinoma by Multiplex PCR and Ultra-Deep Sequencing
26. Promoter regulation of the miR-29a/b1 gene by transforming growth factor-β in hepatic stellate cells and in hepatoma cells
27. The pluripotency involved factors, Lin28 and Notch1 are targets of neuronal miRNAs in hepatic stellate cells
28. The role of miR-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS
29. miR-125b regulates the Lin-28/IGF-II axis during hepatocellular carcinogenesis
30. Next generation sequencing of the Ago2 interacting transcriptome identified chemokine family members as novel targets of neuronal microRNAs in hepatic stellate cells
31. miR-198 controls migration in hepatocellular carcinoma by regulation of Claudin 1
32. The PP2A signaling pathway is a druggable target in murine and human hepatocellular carcinoma
33. Transcriptional promoter regulation of the miR-29a/b1 gene in hepatoma cells
34. miR–101 im komplexen Zusammenspiel von Steatose und Steatohepatitis bei Nicht-Alkoholischen Fettlebererkrankungen
35. Sekretionsprofile extrazellulärer miRNA nach myofibroblastischer Transdifferenzierung Hepatischer Sternzellen: Neue Biomarker der Fibrose?
36. TGF-beta mediates transcriptional repression of miR–29 a/b1 during liver fibrosis
37. The loss of miR–198 is crucial for development and progression of hepatocellular carcinoma
38. Viral infection sensitizes hepatocytes towards TNF-induced apoptosis
39. Identifizierung von neuen microRNA-Zieldomänen während der myofibroblastischen Transdifferenzierung von hepatischen Sternzellen durch "Next Generation Sequencing"
40. Retrograde Perfusion mit Carboxyfluorescein Diacetate Succinimidyl Ester (CFDA-SE): eine neue Methode zur Visualisierung von Gallengängen und Lebergefäßen und zur Isolierung vitaler Cholangiozyten in der Maus
41. Identification and characterization of FoxP1 as a candidate tumor suppressor gene in neuroblastoma
42. A novel non-MHC-I restricted CTL effector function mediated by TNF and XIAP
43. The pluripotency factor LIN28 is targeted by neuronal microRNAs participating in myofibroblastic differentiation
44. The tumor suppressor, miR-198, affects central pathways in tumorigenesis and in the immune response of hepatocellular carcinoma cells
45. Hepatocyte growth factor (HGF) acts as an antifibrotic mediator by prominent miRNA-29 induction
46. New targets of miR-29 in cell communication during liver fibrogenesis
47. Keratin 8 Variants are Associated with Cryptogenic Hepatitis
48. Hepatitis E Virus in LeberBiopsien von Patienten mit akuter Hepatitis unbekannter Ätiologie
49. Kombinationstherapie aus Telmisartan und Propranolol verhindert die histologische Progression der Leberfibrose und Gallengangsproliferation im PSC-ähnlichen Abcb4 –/– Mausmodell
50. Modulation of fibrogenic factors in hepatic stellate cells by Vitamin D and reduction of Vitamin D in NAFLD patients: Implications for NAFLD therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.